Prescribed opioids in primary care: cross-sectional and longitudinal analyses of influence of patient and practice characteristics

Abstract

ObjectivesTo examine trends in opioid prescribing in primary care, identify patient and general practice characteristics associated with long-term and stronger opioid prescribing, and identify associations with changes in opioid prescribing.DesignTrend, cross-sectional and longitudinal analyses of routinely recorded patient data.Setting111 primary care practices in Leeds and Bradford, UK.ParticipantsWe observed 471 828 patient-years in which all patients represented had at least 1 opioid prescription between April 2005 and March 2012. A cross-sectional analysis included 99 847 patients prescribed opioids between April 2011 and March 2012. A longitudinal analysis included 49 065 patient-years between April 2008 and March 2012. We excluded patients with cancer or treated for substance misuse.Main outcome measuresLong-term opioid prescribing (4 or more prescriptions within 12 months), stronger opioid prescribing and stepping up to or down from stronger opioids.ResultsOpioid prescribing in the adult population almost doubled for weaker opioids over 2005–2012 and rose over sixfold for stronger opioids. There was marked variation among general practices in the odds of patients stepping up to stronger opioids compared with those not stepping up (range 0.31–3.36), unexplained by practice-level variables. Stepping up to stronger opioids was most strongly associated with being underweight (adjusted OR 3.26, 1.49 to 7.17), increasing polypharmacy (4.15, 3.26 to 5.29 for 10 or more repeat prescriptions), increasing numbers of primary care appointments (3.04, 2.48 to 3.73 for over 12 appointments in the year) and referrals to specialist pain services (5.17, 4.37 to 6.12). Compared with women under 50 years, men under 50 were less likely to step down once prescribed stronger opioids (0.53, 0.37 to 0.75).ConclusionsWhile clinicians should be alert to patients at risk of escalated opioid prescribing, much prescribing variation may be attributable to clinical behaviour. Effective strategies targeting clinicians and patients are needed to curb rising prescribing, especially of stronger opioids.

What proportion of patients with chronic noncancer pain are prescribed an opioid medicine? Systematic review and meta‐regression of observational studies

“…strong or weak). The prescription of some types of opioids such as oxycodone has increased over time , but our meta‐regression analysis determined that year was not associated with the prevalence of weak, strong or combination opioid analgesics in patients with chronic noncancer pain. The prescribing of opioids to patients with chronic low back pain significantly increased over time, but other study‐level factors were unable to explain any associations of opioid prescribing in this population.…”

“…Global opioid prescribing doubled between 2001–03 and 2011–13 . Several developed countries have noted substantial increases in opioid prescriptions including the United States of America (USA) , Canada , the United Kingdom (UK) , Scotland and Australia , and also for some strong prescription opioids such as oxycodone .…”

Effectiveness of interventions on the appropriate use of opioids for noncancer pain among hospital inpatients: A systematic review

“…This review supports the use of certain interventions to improve the safe and efficacious use of opioids, although the definition of opioid appropriateness varied, depending on the context in which the study was conducted. Earlier interventions conducted in the context of inadequate pain treatment encouraged opioid use as effective analgesic agents, before the focus of appropriate use shifted to potential opioid‐related harms . No consensus could be established from the reviewed articles on the definition of opioid appropriateness.…”

Managing addiction to prescribed opioids: the job of general practice?

“…A study of the duration and potency of opioid analgesic prescribing in general practices in Leeds and Bradford to patients without cancer found an association between higher potency of drugs and longer duration of prescribing, with greater number of medications prescribed, increasing number of practice appointments, and referrals to pain clinics. 7 The authors describe marked variations in stepping up and stepping down prescribing of opioid drugs between different practices. They were not able to explain this variation in prescribing practice but it could relate to training, culture within the practice, and patient expectations.…”